Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial.
Brodowicz
T
T
Kotz
R
R
Wiltschke
C
C
Zielinski
C C
CC
Ritschl
P
P
D000671:Amputation, Surgical / Q000706:statistics & numerical data; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005121:Extremities; D006801:Humans; D007371:Interferon-gamma / Q000008:administration & dosage; D008558:Melphalan / Q000008:administration & dosage; D015337:Multicenter Studies as Topic; D012509:Sarcoma / Q000188:drug therapy* / Q000556:secondary* / Q000601:surgery; D016019:Survival Analysis; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage
D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma; D008558:Melphalan